By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Irish drug development services firm Icon said this week that it has signed an agreement with Empire Genomics to provide personalized medicine development services.
Registering provides access to this and other free content.
Already have an account?Login Now.
Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses.
In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcrips, and more.
After seeing Rich's image of the DNA double helix structure in 1973, James Watson called Rich and told him that it was the first time in 20 years he'd had a good night's sleep.
In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.